Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Investor Alert: Lawsuit Alleges Securities Laws Violations
An investor, who purchased shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX), filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Nymox Pharmaceutical Corporation in connection with certain allegedly false and misleading statements made between January 31, 2011 and November 2, 2014.
View full press release